DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

08037 CH BIOTECH SER

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Liu Xiaolin (54.38%)
Ko Chun Shun, Johnson (9.79%)
Sector Health Care & Biotechnology
Web Site http://www.cbshhk.com Tel (852) 3188-3333
Email info@chinabioservices.com Fax (852) 2151-3968
Related Equities N/A
Principal Activities The Group engaged in the (i) provision of medical laboratory testing services and health check services in Hong Kong; (ii) provision of tumor immune cell therapy and health management services in the People’s Republic of China (the “PRC”); (iii) sale and distribution of health related and pharmaceutical products in the PRC and Hong Kong; and (iv) provision of insurance brokerage.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
劉小林 666,300,546(L) 20,000,000(S)  71.19(L) 2.13(S)  11/09/2018
邱永耀 665,520,546(L) 20,000,000(S)  71.11(L) 2.13(S)  11/09/2018
Central Huijin Investment Ltd. 47,600,000(L)  5.56(L)  23/08/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Wang Zheng 4,000,000(L)  0.47(L)  12/01/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top